Verastem Inc has a consensus price target of $21.61 based on the ratings of 9 analysts. The high is $36 issued by Mizuho on August 29, 2023. The low is $5 issued by BTIG on October 5, 2022. The 3 most-recent analyst ratings were released by Truist Securities, Alliance Global Partners, and RBC Capital on July 8, 2024, May 29, 2024, and May 28, 2024, respectively. With an average price target of $18 between Truist Securities, Alliance Global Partners, and RBC Capital, there's an implied 442.17% upside for Verastem Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/08/2024 | Buy Now | 442.17% | Truist Securities | Srikripa Devarakonda | $34 → $18 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | 502.41% | Alliance Global Partners | Jeff Grampp | $34 → $20 | Maintains | Buy | Get Alert |
05/28/2024 | Buy Now | 381.93% | RBC Capital | Gregory Renza | $32 → $16 | Maintains | Outperform | Get Alert |
05/28/2024 | Buy Now | 427.11% | HC Wainwright & Co. | Sean Lee | $17.5 → $17.5 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | 427.11% | HC Wainwright & Co. | Sean Lee | → $17.5 | Reiterates | Buy → Buy | Get Alert |
03/19/2024 | Buy Now | 427.11% | HC Wainwright & Co. | Sean Lee | → $17.5 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | Buy Now | 863.86% | RBC Capital | Gregory Renza | → $32 | Reiterates | Outperform → Outperform | Get Alert |
11/21/2023 | Buy Now | 713.25% | BTIG | Justin Zelin | → $27 | Assumes | → Buy | Get Alert |
11/15/2023 | Buy Now | 924.1% | Truist Securities | Srikripa Devarakonda | $39 → $34 | Maintains | Buy | Get Alert |
09/29/2023 | Buy Now | 532.53% | B. Riley Securities | Kalpit Patel | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
09/27/2023 | Buy Now | 532.53% | B. Riley Securities | Kalpit Patel | → $21 | Initiates | → Buy | Get Alert |
08/29/2023 | Buy Now | 984.34% | Mizuho | Mara Goldstein | → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | Buy Now | 863.86% | RBC Capital | Gregory Renza | $34 → $32 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | 1074.7% | Truist Securities | Srikripa Devarakonda | $60 → $39 | Maintains | Buy | Get Alert |
07/06/2023 | Buy Now | 924.1% | Cantor Fitzgerald | Alethia Young | → $34 | Reiterates | Overweight → Overweight | Get Alert |
07/03/2023 | Buy Now | 924.1% | RBC Capital | Gregory Renza | $36 → $34 | Maintains | Outperform | Get Alert |
06/27/2023 | Buy Now | 1707.23% | Truist Securities | Srikripa Devarakonda | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | Buy Now | 1707.23% | Truist Securities | Srikripa Devarakonda | → $60 | Reiterates | Buy → Buy | Get Alert |
06/15/2023 | Buy Now | 984.34% | Mizuho | Mara Goldstein | $24 → $36 | Upgrade | Neutral → Buy | Get Alert |
05/10/2023 | Buy Now | -39.76% | HC Wainwright & Co. | Sean Lee | $36 → $24 | Maintains | Buy | Get Alert |
03/30/2023 | Buy Now | -39.76% | Mizuho | Mara Goldstein | → $24 | Initiates | → Neutral | Get Alert |
03/15/2023 | Buy Now | -9.64% | RBC Capital | Gregory Renza | → $36 | Reiterates | → Outperform | Get Alert |
03/15/2023 | Buy Now | -9.64% | HC Wainwright & Co. | Sean Lee | → $36 | Reiterates | → Buy | Get Alert |
11/07/2022 | Buy Now | -9.64% | HC Wainwright & Co. | Sean Lee | $60 → $36 | Maintains | Buy | Get Alert |
10/05/2022 | Buy Now | 50.6% | BTIG | Robert Hazlett | $96 → $60 | Maintains | Buy | Get Alert |
04/14/2022 | Buy Now | 50.6% | RBC Capital | Gregory Renza | → $60 | Initiates | → Outperform | Get Alert |
03/09/2022 | Buy Now | 80.72% | Truist Securities | Srikripa Devarakonda | → $72 | Initiates | → Buy | Get Alert |
The latest price target for Verastem (NASDAQ:VSTM) was reported by Truist Securities on July 8, 2024. The analyst firm set a price target for $18.00 expecting VSTM to rise to within 12 months (a possible 442.17% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for Verastem (NASDAQ:VSTM) was provided by Truist Securities, and Verastem maintained their buy rating.
The last upgrade for Verastem Inc happened on June 15, 2023 when Mizuho raised their price target to $36. Mizuho previously had a neutral for Verastem Inc.
There is no last downgrade for Verastem.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verastem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verastem was filed on July 8, 2024 so you should expect the next rating to be made available sometime around July 8, 2025.
While ratings are subjective and will change, the latest Verastem (VSTM) rating was a maintained with a price target of $34.00 to $18.00. The current price Verastem (VSTM) is trading at is $3.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.